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RESEARCH ARTICLE
An intracellular activation of Smoothened that is independent of
Hedgehog stimulation in Drosophila
Kai Jiang, Yajuan Liu, Jie Zhang and Jianhang Jia*
ABSTRACT
Smoothened (Smo), a GPCR family protein, plays a critical role in
the reception and transduction of Hedgehog (Hh) signal. Smo
is phosphorylated and activated on the cell surface; however, it is
unknown whether Smo can be intracellularly activated. Here, we
demonstrate that inactivation of the ESCRT-III causes dramatic
accumulation of Smo in the ESCRT-III/MVB compartment, and
subsequent activation of Hh signaling. In contrast, inactivation of
ESCRTs 0–II induces mild Smo accumulation in the ESCRT-III/MVB
compartment. We provide evidence that Kurtz (Krz), theDrosophila β-
arrestin2, acts in parallel with the ESCRTs 0-II pathway to sort Smo to
the multivesicular bodies and lysosome-mediated degradation.
Additionally, upon inactivation of ESCRT-III, all active and inactive
forms of Smo are accumulated. Endogenous Smo accumulated upon
ESCRT-III inactivation is highly activated, which is induced by
phosphorylation but not sumoylation. Taken together, our findings
demonstrate a model for intracellular activation of Smo, raising the
possibility for tissue overgrowth caused by an excessive amount,
rather than mutation of Smo.
KEY WORDS: ESCRT, Hh, Smo, Vps20, Vps32, Signal transduction
INTRODUCTION
Hedgehog (Hh) signaling controls organ development, tissue
homeostasis and body patterning. Malfunction of Hh signaling
causes birth defects as well as several types of cancer (Briscoe and
Thérond, 2013; Jiang and Hui, 2008). In Drosophila, the Hh signal
is transduced at the plasma membrane, where the receptor complex
Patched–Interference Hh (Ptc–Ihog) and the signal transducer
Smoothened (Smo) are located. Hh binding to Ptc–Ihog relieves
Ptc-mediated inhibition of Smo, which results in Smo activation and
then the activation of the Cubitus interruptus (Ci)/Gli family of zinc
finger transcription factors, and ultimately induces the expression of
Hh target genes, such as decapentaplegic (dpp), ptc, collier (col)
and engrailed (en) (Hooper and Scott, 2005; Jia and Jiang, 2006).
Smo is a member of the G protein-coupled receptor (GPCR) family
and acts as a key regulator of the pathway for both insects and
vertebrates. Abnormal activation of Smo results in basal cell
carcinoma (BCC) and medulloblastoma; thus Smo has been an
attractive therapeutic target exemplified by recent US Food and
Drug Administration (FDA)-approved Smo inhibitors for treating
cancer driven by Smo dysregulation (Pak and Segal, 2016).
Studies have shown that Hh induces cell surface accumulation
and phosphorylation of Smo by protein kinase A (PKA), casein
kinase 1 (CK1), casein kinase 2 (CK2), and G protein-coupled
receptor kinase 2 (Gprk2) (Chen and Jiang, 2013; Jiang and Jia,
2015), as well as atypical PKC (aPKC) (Jiang et al., 2014).
Differential phosphorylation and gradual conformational change in
Smo mediates the transduction of Hh activity gradient (Fan et al.,
2012; Zhao et al., 2007). The cell surface accumulation of Smo is
also regulated by endocytosis; ubiquitylation promotes Smo
endocytosis and de-ubiquitylation by Ubiquitin-specific protease
8 (USP8) inhibits Smo endocytosis, which ultimately promotes its
cell surface accumulation (Li et al., 2012; Xia et al., 2012).
Membrane accumulation and activation of Smo is further regulated
by small ubiquitin-like modifier (SUMO) through sumoylation (Ma
et al., 2016; Zhang et al., 2017). These findings indicate that cell
surface accumulation promotes the activation of Smo; however, it is
unknown whether and how Smo can be activated intracellularly.
Many GPCRs use the intracellular route to activate downstream
genes. Studies on GPCRs have demonstrated that activation of
receptors, and consequent activation of downstream components,
often stimulate the receptor endocytosis (Irannejad and von Zastrow,
2014; Sorkin and von Zastrow, 2009). This process may function as
a feedback regulation to prevent excessive ligand-induced activation
of downstream effectors (Sorkin and von Zastrow, 2009). In
addition, GPCR phosphorylation and their association with β-
arrestins play a major role in this process (Irannejad and von
Zastrow, 2014). Molecular sorting machineries determine their
ultimate trafficking fate, as receptors either recycle back to the cell
surface or are targeted for lysosomal degradation. Unlike other
GPCRs, Smo is activated and accumulated on the cell surface upon
Hh stimulation. It is unknown whether Smo undergoes intracellular
signaling along the endocytic pathway.
The endosomal sorting complex required for transport (ESCRT)
machinery includes four ESCRT complexes (ESCRT-0, -I, -II, -III)
and Vacuolar protein sorting 4 (Vps4), and these machineries
mediate the selection and transport of proteins destined for
lysosomal degradation (Hurley and Hanson, 2010; Wollert and
Hurley, 2010). ESCRT facilitates ubiquitylated protein trafficking
from endosomes to lysosomes via multivesicular bodies (MVBs)
(Henne et al., 2011; Raiborg and Stenmark, 2009; Williams and
Urbé, 2007). Clathrin-dependent endocytosis mediates the
activation of epidermal growth factor receptor (EGFR), which is
further sorted to the MVB then is trafficked to the lysosome (Goh
et al., 2010). The ESCRTs 0–III protein complexes drive MVB
cargo selection; however, ESCRT-III does not directly interact with
ubiquitin. Many membrane-bound proteins are actively sorted to
different places in the cell from the early endosome (Hurley and
Hanson, 2010). In Drosophila Smo trafficking, the homologs of the
ESCRT members mediate sorting of ubiquitylated Smo to
endosomes. Smo accumulation is observed upon the inactivation of
the ESCRT proteins, such as the Hepatocyte growth factor-regulatedReceived 21 September 2017; Accepted 13 November 2017
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tyrosine kinase substrate (Hrs), a protein that acts within ESCRT-0
(Fan et al., 2013; Li et al., 2012), Tumor susceptibility gene 101
(Tsg101) in ESCRT-I (Fan et al., 2013; Li et al., 2012), and Vps36
in ESCRT-II (Yang et al., 2013). However, inactivation of the
proteins of the early endosome, late endosome, or the ESCRTs 0–II
causes a mild accumulation of Smo, which is thought to
contribute to the cell membrane accumulation and activation of
Smo. It is unknown whether Smo can be activated in the
intracellular compartments, similar to the activation of many other
GPCRs.
In this study, we found that inactivation of the ESCRT-III core
subunits, Vps32 (also known as Shrub inDrosophila, Snf7 in yeast,
and CHMP4 in mammal) and Vps20 (CHMP6 in mammals),
caused a dramatic increase in Smo. Surprisingly, inactivation of
either Vps32 or Vps20 induced ectopic Hh target gene expression at
higher levels compared to that induced by the inactivation of
proteins in the ESCRTs 0–II. Furthermore, we found that Smo was
activated in ESCRT-III-containing compartments, which did not
rely on Hh stimulation and was not inhibited by Ptc, indicating that
Smo activation can occur in an Hh- and Ptc-independent manner.
Moreover, Smo ubiquitylation and sumoylation were not changed in
ESCRT-III-containing compartments. To explore the mechanism
for intracellular Smo accumulation, we identified a Krz-mediated
pathway, operating in parallel to endocytosis, that directs Smo to the
ESCRT-III complex and the MVB, which accounts for the high
accumulation and activation of Smo. These findings indicate that
Smo can be intracellularly activated, and that activated Smo at a
certain threshold may result in high levels of Hh signaling activity.
RESULTS
Inactivation of ESCRT-III results in a high level of Smo and
activates Hh target gene expression
Previous studies have shown that Smo undergoes lysosomal
degradation that is triggered by ubiquitin-mediated endocytosis
(Fan et al., 2013; Li et al., 2012; Xia et al., 2012). However, it
has been puzzling that, in cultured S2 cells, the majority
of Smo is present in large puncta that do not colocalize with
ubiquitin (Fig. S1A). In Drosophila wing discs, the developing
wing, posterior (P) compartment cells express and secrete Hh that
activates adjacent anterior (A) compartment target gene expression,
which is mediated by the Ci transcription factor. The low level of
Smo in A-compartment cells away from the A/P boundary indicates
a rapid protein degradation (Fig. 1A). In wing discs treated with
bafilomycin A1 (BFA1) to selectively inhibit vacuolar ATPases that
mediate the delivery of internalized proteins from MVB to
lysosome, Smo was present in puncta in A- and P-compartment
cells (Fig. S1C, compare to Fig. S1B), suggesting that Smo is
indeed trafficked from the MVB to the lysosome for degradation.
It is possible that the large puncta of Smo observed in S2 cells are
located in larger intracellular compartments, such as the MVB.
To better understand the intracellular trafficking of Smo, we
collected RNAi lines from different sources to target ESCRT
protein expression. We found that knockdown of Vps32 by RNAi
resulted in a high level of accumulation of Smo and Ci (Fig. S2A).
The level of Ptc protein was also increased in A-compartment cells,
indicating activation of the Hh pathway (Fig. S2B). To more
precisely examine the accumulation of Smo in wing discs, we used
either P35, a cell death inhibitor, or the inducible Gal80ts system to
prevent cell death induced by Vps32 RNAi. We found that Smo
showed high levels of accumulation under both conditions (Fig. 1B,
C, gray panel). We also found that the Smo accumulation caused by
Vps32 RNAi in large part did not colocalize with Hrs (marks the
ESCRT-0 complex) or Rab7 (marks the late endosome) (Fig. 1D;
Fig. S2C), but mostly colocalized with lysosome-associated
membrane protein 1 (LAMP1) (Fig. 1E), which labels the MVB
and lysosome (Pulipparacharuvil et al., 2005; Williams and Urbé,
2007). The expression of LAMP1–GFP alone did not cause any
phenotype in vivo (Pulipparacharuvil et al., 2005), and did not
change Smo accumulation (Fig. S2D). GFP-tagged Vps32 (Vps32–
GFP) has shown to be a dominant negative (Sweeney et al., 2006).
We found that Vps32–GFP colocalized with Smo, and induced Smo
and Ci accumulation in the wing disc, likely by blocking the
function of endogenous Vps32 (Fig. S2E,F). These data suggest that
the inactivation of Vps32 causes a dramatic accumulation of Smo,
which is likely localized in the MVB.
To examine whether the inactivation of Vps32 regulates the
activity of Smo, we first used a sensitized genetic background by
expressing the partial dominant-negative SmoDN that we previously
described as Smo−PKA12. In this protein, two PKA phosphorylation
sites are mutated to avoid phosphorylation (Jia et al., 2004).
Expressing SmoDN through the wing-specific C765-Gal4, a weaker
Gal4 line than MS1096-Gal4, resulted in a reproducible phenotype
of partial fusion between vein 3 and vein 4, indicative of
partial loss of Hh signaling activity (Fig. S2H, compare to WT
wing in Fig. S2G). We found that Vps32 RNAi reversed the activity
of SmoDN, resulting in a rescue of the vein 3–vein 4 fusion
phenotype (Fig. S2I). In comparison, Vps32 RNAi driven by C765-
Gal4 produced a mild phenotype in the adult wing (Fig. S2J). These
data indicate that inactivation of Vps32 regulates the activity of
Smo. We further examined Smo accumulation in Vps32 mutant
cells and found that Smo showed a dramatic accumulation in Vps32
mutant cells (Fig. 1F). Surprisingly, mutating Vps32 induced
expression of En, a marker for the peak activation of Hh signaling
(Fig. 1G). We next investigated cultured S2 cells and found that the
levels of Smo were increased upon both Vps32 RNAi and Hh
treatment, and that the accumulation of Smo reached a peak level
when Vps32 RNAi and Hh treatment were combined (Fig. 1H).
Consistent with this, Vps32 RNAi significantly increased the
ptc-luciferase ( ptc-luc) reporter activity, which was further
increased upon Hh treatment (Fig. 1I). In these experiments, very
high RNAi efficiency was achieved and monitored by quantitative
real-time PCR (qRT-PCR) (Fig. 1J). In a cell-based assay to
examine Smo cell surface accumulation, Hh treatment consistently
increased the accumulation of Smo on the cell surface (Jia et al.,
2004) (Fig. 1K); however, the inactivation of Vps32 significantly
increased Smo accumulation inside the cell but not on the cell
surface (Fig. 1K). These data suggest that Smo can be intracellularly
activated during a malfunction of ESCRT-III.
To further examine the ESCRT-III-mediated regulation of Smo
accumulation and activation, we used a mutant of Vps20, which is
another critical protein in the ESCRT-III complex. We found a high
accumulation of Smo in cells with mutated Vps20 (Fig. 2A).
Consistent with the finding that mutating Vps32 induced Hh target
gene expression (Fig. 1G), mutation of Vps20 induced ectopic
expression of dpp-lacZ and ptc-lacZ, indicating that Smo activates
Hh target gene expression in cell autonomous manner (Fig. 2B,C;
Fig. S3 for higher magnification images). In cultured cells, we
found that knockdown of Vps20 by RNAi significantly increased
the ptc-luc activity (Fig. 1I); however, it did not increase the amount
of cell surface-localized Smo (Fig. 1K). These data confirmed the
activation of Smo upon ESCRT-III loss of function. These findings
were very interesting because inactivation of the ESCRT-0,
ESCRT-I and ESCRT-II increases the cell surface accumulation
of Smo but does not significantly increase Hh target gene expression
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Fig. 1. See next page for legend.
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(Fan et al., 2013; Li et al., 2012; Yang et al., 2013), and we therefore
did not expect Smo to be activated in the intracellular compartment.
Smo is phosphorylated and activated in ESCRT-III-
containing compartments
To determine the active/inactive status of Smo in the intracellular
compartment, we first examined the ability of Ptc to inhibit Smo
activation. We found that overexpression of Ptc inhibited Smo
accumulation and decreased the level of Ci in wild-type cells of the
wing disc but not in Vps20-depleted cells (Fig. 2D). We also
examined the levels of endogenous Ptc protein and found that Ptc
accumulated upon Vps20 mutation (Fig. 2E); however, the
accumulated Ptc, similar to exogenously expressed Ptc protein, did
not inhibit Smo (Fig. 2A). These data suggest that the accumulation
of Smo in the ESCRT-III-containing/MVB compartment is not
inhibited by Ptc. To further examine the localization of Smo, we
immunostained thewing disc forVps4 that labels protein localization
close to the ESCRT-III/MVB (Rodahl et al., 2009). We found that
Smo colocalized with Vps4 in cells mutating Vps20 (Fig. 2F). Taken
together with the finding that RNAi interference of Vps32 led to the
accumulation of Smo (in puncta marked by LAMP1), our data
suggest that the inactivation of ESCRT-III causes Smo accumulation
in the MVBs.
To delineate whether the activation of Smo upon inactivation of
ESCRT-III required Hh stimulation, we simultaneously inactivated
both Hh and Vps32 and examined Smo accumulation in the wing
disc. We found that Vps32 RNAi consistently increased Smo
accumulation and induced ectopic ptc-lacZ expression regardless of
the presence or absence of Hh RNAi (Fig. 3B, compared to Fig. 3A
and Fig. S2A), suggesting that the intracellular activation of Smo
does not rely on Hh stimulation. Hh RNAi alone blocked Smo
accumulation and inhibited ptc-lacZ expression (Fig. 3C). To
determine whether Smo existed in an active form, we performed
immunostaining with an antibody against phosphorylated Smo
(denoted SmoP) to examine Smo phosphorylation in the wing disc.
ExogenousMyc–SmoWTwas expressed in thewing disc because the
anti-SmoP antibody is unable to detect the phosphorylation of
endogenous Smo. Consistent with previous findings (Fan et al.,
2012), phosphorylated Smo was detected in P-compartment cells
where therewas Hh stimulation (Fig. 3D).We found that inactivation
of Vps32 by RNAi increased the levels of Smo phosphorylation
in the P-compartment cells as well as in the A-compartment cells
away from the A/P boundary, suggesting an Hh-independent
phosphorylation of Smo (Fig. 3E). We again used a cell-based
assay to examine the levels of Smo phosphorylation and found that
RNAi of Vps32 increased Smo phosphorylation, which was
similar to what was seen upon Hh treatment (Fig. 3F). These data
suggest that the Smo that accumulates upon Vps32 RNAi is in its
active forms.
Recent studies have demonstrated that Smo is activated by
sumoylation that is induced by Hh (Ma et al., 2016; Zhang et al.,
2017). We therefore wondered whether the intracellularly
accumulated Smo was sumoylated. Using the cell-based assay, we
found that, in contrast to Hh treatment, inactivation of Vps32 by
RNAi did not change the status of Smo sumoylation (Fig. 3G),
suggesting that the inactivation of Vps32 increases the levels of Smo
and induces Smo phosphorylation that ultimately promotes Hh
signaling. We also examined the ubiquitylation status of Smo and
found that knockdown of Vps32 by RNAi did not change the levels
of ubiquitylation for either wild-type Smo (SmoWT) or the
phosphorylation-mimetic active form of Smo (SmoSD123)
(Fig. 3H). These findings suggest that intracellular Smo activation
does not require sumoylation and is not mediated by
deubiquitylation, pointing to a different mechanism from that
utilized for cell membrane Smo activation.
Inactivation of ESCRT-III results in an accumulation of
different forms of Smo
The unchanged levels of Smo sumoylation and ubiquitylation upon
Vps32 inactivation led us to examine the stability of the different
forms of Smo to determine which form of Smo accumulates in the
ESCRT-III-containing compartment. We carried out a protein
stability analysis by transfecting S2 cells with Myc–SmoWT, Myc–
SmoPKA123 (the phosphorylation-deficient, inactive form of Smo)
and Myc–SmoSD123, and then monitoring Smo levels upon the
inactivation of Vps32. We then performed western blot analysis to
examine the stability of the different forms of Smo and found that
knockdown of Vps32 by RNAi increased the levels of all forms of
Smo (Fig. 4A). We further found that the ubiquitylation-deficient
forms of Smo [SmoK6R, SmoK42R and SmoKallR (described by Yang
et al., 2013)], were all increased upon Vps32 RNAi (Fig. 4B). These
data suggest that ESCRT-III regulates different forms of Smo. We
Fig. 1. Inactivation of Vps32 induces the accumulation of Smo and the
activation of Hh target gene expression. (A) A wild-type wing disc was
immunostained for Smo, Ci and ptc-lacZ (PtcZ). Smo is stabilized in
P-compartment cells (arrow) as well as A-compartment cells near the A/P
boundary (arrowhead) where Hh stimulation occurs. The dashed yellow line
indicates the A/P boundary as defined by Ci staining. (B) Awing disc from flies
expressing UAS-Vps32RNAi and UAS-P35 from the wing-specific MS1096-
Gal4 at 19°C was immunostained for Smo, Ci, and ptc-lacZ. Arrows indicate
the accumulation of Smo (gray) and Ci (red) in A-compartment cells, and the
arrowhead indicates Smo accumulation in P-compartment cells. (C) A wing
disc expressing UAS-Vps32RNAi driven by MS1096-Gal4 together with tub-
Gal80ts for 4 days at 29°C (non-permissive temperature) to inhibit Gal80
expression was stained for Smo, Ci and ptc-lacZ. The arrow indicates the
accumulation of Smo in A-compartment cells. The mild accumulation of Ci
shown in B and C was either due to the low temperature or the short time of
induction. (D) A high-magnification image from a wing disc expressing UAS-
Vps32RNAi and UAS-P35 driven by MS1096-Gal4 and immunostained for
Smo and Hrs. The arrowhead indicates Smo colocalization with Hrs and the
arrow indicates the non-Hrs-colocalized Smo. (E) A high-magnification image
from a wing disc expressing UAS-Vps32RNAi and UAS-P35 together with
UAS-LAMP1-GFP driven by MS1096-Gal4 and immunostained for Smo and
GFP. (F,G) Wing discs carrying vps32 mutant clones generated by flippase-
mediated mitotic recombination were immunostained for Smo, En and GFP.
Clones are marked by the lack of GFP expression. The arrows indicate the
accumulation of Smo and the expression of En in vps32−/− cells; the arrowhead
shows En expression induced by Hh in P-compartment cells. P35 was
expressed through the MS1096-Gal4 to inhibit cell death. (H) S2 cells were
transfected with Myc–SmoWT and treated with Vps32 dsRNA or HhN-
conditioned medium. Cell extracts were immunoprecipitated (IP) and analyzed
by western blotting (WB) using the anti-Myc antibody to examine the levels of
Smo. Western blots stained with the anti-GFP antibody served as a
transfection and loading control. (I) A ptc-luc reporter assay to examine Hh
signaling activity. S2 cells were transfected with Myc–SmoWT and tub-Ci, and
treated with HhN-conditioned medium or control medium, together with the
treatment of Vps32 dsRNA or Vps20 dsRNA. The y-axis represents
normalized ptc-luc activity. †P<0.005 versus SmoWT expression alone in the
first column (Student’s t-test). *P<0.005 versus SmoWT treated with Hh in the
second column (Student’s t-test). (J) RNAi efficiency for Vps32 and Vps20. For
Vps32 RNAi targeting different regions of Vps32, dsRNA1 and dsRNA2 alone
or together gave rise to similar knockdown efficiency, thus dsRNA1 was used
for most of the experiments. (K) S2 cells were transfected with the CFP-Smo
construct, treated with Hh-conditioned medium or control medium, or treated
with the indicated dsRNA of Vps32 and Vps20, followed by immunostaining
with the anti-SmoN antibody before membrane permeabilization to label cell
surface-localized Smo (top panel of cells). The CFP signal indicates the total
Smo expressed (whole cell signal). A quantification of the cell surface to total
Smo levels as a percentage is shown (n≥15; mean±s.d.).
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Fig. 2. Vps20 loss-of-function induces high levels of Smo accumulation and Hh signaling activation. (A) A wing disc carrying vps20 mutant clones was
immunostained for Smo, Ci and GFP. Clones are marked by the lack of GFP expression. Arrows indicate high accumulation of Smo and Ci. (B,C) Wing discs
carrying vps20mutant clones were immunostained for GFP, dpp-lacZ (DppZ) or ptc-lacZ (PtcZ). The arrows identify the ectopic expression of dpp-lacZ and ptc-
lacZ. (D) Awing disc carrying vps20mutant clones and expressing UAS-HA-Ptc driven byMS1096-Gal4 was immunostained for Smo, Ci and GFP. The arrows
show a high accumulation of Smo and Ci not inhibited by Ptc expression in vps20mutant cells. The arrowheads identify the inhibition of Smo and Ci accumulation
in vps20 wild-type cells. (E) A wing disc carrying vps20 mutant clones was immunostained for Ptc and GFP. The arrow indicates a high accumulation of Ptc
protein. (F) High-magnification of a wing disc carrying vps20 mutant clones and immunostained for Smo, Vps4, and GFP. Arrows indicate the colocalization of
Smo with Vps4.
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Fig. 3. Smo is phosphorylated and
activated by Vps32RNAi in wing disc.
(A–C) Wing discs from flies expressing
UAS-Vps32RNAi and UAS-HhRNAi
alone or together driven by MS1096-
Gal4 were stained for Smo, ptc-lacZ
(PtcZ) and Ci. A control experiment is
shown in C, with arrows indicating the
blocked accumulation of Smo (arrow in
gray image), inhibited expression of ptc-
lacZ (arrow in green image) and
inhibited activation of Ci (arrow in red
image). Of note, co-expressing
Vps32RNAi with HhRNAi caused a very
similar phenotype to that seen upon
expressing Vps32RNAi alone.
(D,E) Higher magnification images of
wing discs from flies expressing Myc–
SmoWT alone or together with Vps32
RNAi. Discs were immunostained with
the anti-Myc, anti-Ci and anti-SmoP
antibodies. Of note, the anti-SmoP
antibody can detect phosphorylation of
the overexpressed Smo. (F) S2 cells
were transfected with Myc–SmoWT
followed by the treatment with Vps32
dsRNA or HhN-conditioned medium.
Cell extracts were immunoprecipitated
(IP) with the anti-Myc antibody and
analyzed by western blotting (WB) using
either the anti-SmoP antibody to detect
Smo phosphorylation or the anti-Myc
antibody to monitor the expression of
Myc–SmoWT. Western blots for GFP
served as a transfection and loading
control. Smo was normalized by
previously described methods (see
Materials and Methods). (G) A cell-
based assay to detect the levels of Smo
sumoylation. S2 cells were co-
transfected with Myc–SmoWT, HA–
SUMO and Flag–Ubc9, followed by the
treatment with Vps32 dsRNA, HhN-
conditioned medium or control medium.
Cell extracts were immunoprecipitated
with the anti-Myc antibody and analyzed
by western blotting using the anti-HA
antibody to examine the Smo-bound
SUMO, or with the anti-Myc antibody to
monitor the levels of Smo. Western blots
for GFP served as a transfection and
loading control. Smo was normalized by
the previously described methods (see
Materials and Methods). (H) To examine
Smo ubiquitylation, S2 cells were
transfected with the indicated constructs
followed by treatment with Vps32
dsRNA. Cell lysates were
immunoprecipitated with the anti-Myc
antibody and analyzed by western
blotting using the anti-HA antibody to
examine the Smo-bound ubiquitin, or
with the anti-Myc antibody to monitor the
levels of Smo. Western blots for GFP
served as a transfection and loading
control. Myc–SmoWT and Myc–
SmoSD123 were normalized separately.
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therefore performed a more precise analysis to examine the stability
of the Smo protein at different time points after the treatment by using
the protein synthesis inhibitor cycloheximide (CHX). We found that
the half-lives of SmoWT and SmoSD123 were increased upon Vps32
RNAi (Fig. 4C,D, middle panel), compared to the half-lives of these
forms of Smo in cells without Vps32 knockdown (Fig. 4C,D, left
panel), which was further demonstrated by quantification analyses
(Fig. 4C,D, right panel). These data suggest that the active form of
Smo is sorted through ESCRT-III for lysosome-mediated
degradation.
It has been shown that ubiquitylation at lysine residues of Smo C-
tail promotes, whereas mutating these residues blocks, Smo
endocytosis (Li et al., 2012; Xia et al., 2012; Yang et al., 2013).
Interestingly, we found that SmoK42R, with all 42 lysine residues in
the Smo C-tail mutated to arginine to block Smo ubiquitylation,
accumulated in vps20 mutant cells (Fig. 5B), which was similar to
Fig. 4. The stability of Smo variants regulated by the inactivation of Vps32. (A,B) S2 cells were transfected with the indicated Smo constructs followed
by the treatment with Vps32 dsRNA. Cell extracts were immunoprecipitated with the anti-Myc antibody and analyzed by western blotting with the anti-Myc
antibody to examine the stability of Smo. For a better comparison, images from shorter and longer exposure times are shown. Western blots for GFP served as a
transfection and loading control. (C–E) Smo protein stability assays. S2 cells were transfected with Myc–SmoWT, Myc–SmoSD123 or Myc–SmoK42R, treated
with or without Vps32 dsRNA, and incubated with CHX for the indicated time periods. Cell extracts were immunoprecipitated with the anti-Myc antibody and
analyzed by western blotting with the anti-Myc antibody to examine the levels of Smo protein. The quantification of Smo levels at different time points are shown in
the right panel. Signal density at t=0 was defined as 100%. Data were from three independent experiments for each set. *P<0.05, †P<0.01, #P<0.001 versus Smo
expression without Vps32 dsRNA (Student’s t-test).
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Fig. 5. The signaling activity of
different forms of Smo in vivo.
(A,B) Wing discs carrying vps20
mutant clones and expressing Myc–
SmoWT or Myc–SmoK42R driven by
MS1096-Gal4 were immunostained
for GFP to label the clones, and for
Myc to examine the levels of Smo
inside and outside vps20 clones. The
arrows indicate the elevated levels of
both SmoWTand SmoK42R in cells with
mutated vps20. (C,D) Wing discs
carrying smo mutant clones
immunostained for Ptc, En, Ci and
GFP. Arrows in the red panel indicate
the lack of Ptc or En expression upon
smo mutation. Arrows in the green
panel indicate the clones recognized
by the lack of GFP expression.
(E–H) Wing discs containing smo
mutant clones and expressing
different forms of Smo at the same
attP locus (VK5 75B1) driven by the
tubulin-α promoter were
immunostained for Ptc, En, Ci and
GFP. Arrows in the red panel indicate
the rescue of Ptc or En expression by
the exogenously expressed Smo.
Arrows in the green panel show smo
mutant clones marked by the lack of
GFP expression. Yellow dashed lines
indicate the A/P boundary defined by
Ci staining.
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the observed accumulation of SmoWT in these cells (Fig. 5A). Both
SmoWT and SmoK42R were stabilized by the treatment of BFA1
in cultured S2 cells (data not shown). These data suggest that
SmoK42R is sorted into the ESCRT-III-containing/MVB
compartment through a different route rather than through the
endocytosis pathway. In support of this hypothesis, the half-life of
SmoK42R was increased by knockdown of Vps32 in the cell-based
assay that focused on Smo stability (Fig. 4E). To examine the in vivo
activity of SmoK42R, we used the tubulin-α promoter, which gives
an expression level that is similar to the endogenous Smo expression
level (Jia et al., 2010), and found that SmoK42R rescued ptc and
en expression in smomutant cells (Fig. 5E,F, compare to 5C and 5D,
respectively). The activity of SmoK42R may have two components:
one from Smo accumulation on the membrane due to the blockade
of endocytosis, and the other from the accumulation in the ESCRT-
III-containing/MVB compartment.
Many membrane-bound proteins contain a KKDE motif that
interacts with COP-I coats, which mediate target protein delivery to
the endoplasmic reticulum. Fusion of the KKDE motif at the
C-terminus of Smo removed Smo from the cell surface and
significantly reduces the activity level of the different forms of Smo
(Zhu et al., 2003). To further assess the role of the intracellularly
localized Smo in transducing an Hh signal, we generated SmoKKDE,
with a fused KKDEmotif at the C-terminus, under the control of the
tubulin-α promoter. We found that SmoKKDE was able to rescue
both Ptc and En expression in smo mutant cells (Fig. 5G,H). The
FDNPVY internalization signal from the LDL receptor is a motif
known to promote protein endocytosis (Wang and Struhl, 2004).
We fused a 23-amino-acid peptide that contains the FDNPVY
signal to the C-terminus of Smo (SmoFD). We found that, driven by
the tubulin-α promoter, SmoFD fully rescued both Ptc and En
expression (Fig. S4A,B). Compared to SmoWT, both SmoKKDE and
SmoFD showed a significant reduction in cell surface accumulation
even when there was Hh stimulation (Fig. S4C). These data suggest
that forcing Smo to localize to the intracellular compartment does
not alter its ability to induce Hh target gene expression,
demonstrating the signaling activity of intracellularly localized
Smo.
Krz acts in parallel to the endocytosis pathway to sort Smo to
ESCRT-III
Hrs and Signal transducing adaptor molecule (Stam) constitute the
ESCRT-0 complex responsible for the initial selection of
ubiquitylated proteins that are ultimately degraded in lysosomes
(Henne et al., 2011). We found that RNAi-mediated knockdown of
Hrs caused a mild increase in Smo accumulation (Fig. 6C, compared
to 6A), which is consistent with previous findings (Fan et al., 2013;
Li et al., 2012). We also found a mild accumulation of Smo in hrs
mutant cells (Fig. S6A), and that the double mutation of hrs and
stam did not increase the accumulation of Smo (Fig. S6B). Doubly
mutating hrs and stam was thought to completely block Smo
endocytosis mediated by ESCRT-0. Our findings raise the
possibility that Smo, especially the non-ubiquitylated forms of
Smo, undergoes trafficking/degradation through other mechanisms.
Previous studies showed that Kurtz (Krz), the Drosophila non-
visual arrestin, downregulated Smo accumulation by promoting Smo
degradation in a ubiquitin- and Gprk2-independent manner (Li et al.,
2012; Molnar et al., 2011). Overexpression of Krz prevented Smo
accumulation in wing discs but krz mutation did not (Fig. 6E) (Li
et al., 2012; Zhang et al., 2017). Similarly, we found that knockdown
of Krz by RNAi did not result in any change in Smo accumulation
(Fig. 6B, compared to 6A). However, Smo accumulation was
markedly increased when Krz RNAi and Hrs RNAi were combined
(Fig. 6D, compared to 6B and 6C). In addition, knockdown of Hrs by
RNAi in krz mutant cells resulted in the accumulation of Smo to a
higher level thatn in krz wild-type cells (Fig. 6F). It has been shown
that Vps32 acts as a key modulator in ligand-independent Notch
signaling mediated by Krz and ESCRT-III (Hori et al., 2011). Our
findings led to the hypothesis that Krz and Hrs act in parallel
pathways to regulate Smo trafficking. To further test this hypothesis,
we examined the ability of Krz to inhibit Smo accumulation under a
variety of conditions. We found that, consistent with previous
findings, Krz overexpression completely blocked Smo accumulation
(Fig. 6G). Hrs RNAi caused Smo accumulation in both Krz-
expressing cells (Fig. 6H) and wild-type cells (Fig. 6H,I).
Furthermore, overexpression of Krz inhibited Smo accumulation in
wild-type cells but not in hrs mutant cells (Fig. 6K). These results
indicate that Hrs and Krz act in parallel to regulate Smo.
To determine how ESCRT-I regulates Smo, we examined the
effect of Vps28 loss of function in the ESCRT-I complex. We found
that mutating vps28 induced a moderate accumulation of Smo,
similar to that caused by hrsmutation (Fig. S6C andA, respectively).
The accumulation of Smo in vps28mutant cells was not adequate to
induce Ci accumulation in the wing disc (Fig. S6C). These data
indicate that the same forms of Smo are trafficked from ESCRT-0- to
ESCRT-I-containing compartments. Our finding that bothRNAi and
mutation of Vps32 caused a striking accumulation of Smo in the
ESCRT-III-containing compartment (Figs 1 and 2) suggests that
Smo may sort to the ESCRT-III through an ESCRT-0-independent
pathway. In support of this hypothesis, we found that Krz
overexpression did not inhibit the Smo accumulation that was
induced by Vps32 RNAi (Fig. 6J). The Vps4 complex acts
downstream of ESCRT-III to mediate protein degradation through
lysosomes. Similar to what was seen with Vps32 RNAi (Fig. 3A;
Fig. S2A), Smo accumulation was observed when a dominant-
negative Vps4DN was expressed in wing disc (Fig. S6D). Taken
together, our data suggest that the parallel pathways mediated by Krz
and Hrs may merge at ESCRT-III to direct additional trafficking and
lysosomal degradation.
Autophagy is an evolutionarily conserved, highly regulated
cellular process. Autophagosomes can potentially fuse with
lysosomes, or with early and late endosomes; however, Vps34
and Beclin 1 play selective roles in the autophagy pathway
(Funderburk et al., 2010; Raiborg and Stenmark, 2009). To
examine whether Smo is regulated by the autophagy, we
examined the accumulation of Smo in both wing disc and
cultured S2 cells when autophagy gene expression was knocked
down by RNAi. We found that knockdown of either Vps34 or
Beclin 1 by RNAi did not cause any changes in Smo accumulation
or ptc-lacZ expression in wing disc, although both Vps34 and
Beclin 1 RNAi induced phenotypes in the adult wing (Fig. S5A,B,
data not shown). Consistent with this, inactivation of other
autophagy genes, such as Vps15, Atg8a, Atg8b and Atg7, did not
cause any changes in Smo accumulation and Hh target gene
expression (data not shown). The phenotypes are unlikely to be due
to off-target effects because different lines targeting non-
overlapping regions produced similar phenotypes. We also used
the cell-based assay to examine Smo stability in S2 cells and found
that RNAi for Vps15, Beclin1 and Vps34 did not cause any changes
in the levels of Smo (Fig. S5C). Taken together, we conclude that
the autophagy pathway is not involved in Smo stability control.
There is a possibility for Krz to mediate Smo degradation through
the proteasome (Li et al., 2012). The dilemma was to be able to
distinguish Krz-mediated Smo sorting to the MVB from that to the
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proteasome. We explored the possibility of an interaction of Krz
with different forms of Smo that are representative of different
compartments. We found that endogenous Krz strongly interacted
with transfected Myc–SmoWT, indicating that Krz and Smo were
physically associated (Fig. 7A, lane 1, top panel). We further found
that Krz interacted with SmoK42R at a level comparable to SmoWT,
indicating that mutating the 42 lysine residues in the Smo C-tail did
not change the overall association of Krz with Smo (Fig. 7A, lane 2,
top panel). However, Krz interacted with SmoKKDE and SmoFD at
significantly higher levels than with SmoWT, suggesting that
endoplasmic reticulum-localized Smo (mediated by the KKDE
signal) and endocytosed Smo (promoted by the FDNPVY
internalization signal) are favorably subjected to Krz-mediated
trafficking (Fig. 7A, lanes 3,4, top panel, and quantification analysis
in the right panel). These data suggest that Krz physically interacts
with the endocytosed and endoplasmic reticulum-localized Smo to
promote Smo degradation through lysosomes.
We found that the endogenous Krz protein was very stable and
that its stability was not altered by Vps32 RNAi, MG132 (a potent
proteasome inhibitor), BFA1 or Hh treatment, suggesting that the
endogenous Krz does not undergo degradation through either the
proteasome- or lysosome-mediated pathways (Fig. 7B). We also
found that the endogenous Krz protein was stable and was expressed
in the wing imaginal disc, with a slightly higher level in the wing
pouch, but that no difference was observed between the A-
compartment and P-compartment cells (Fig. 7C), suggesting that
the expression or stability of Krz is not regulated by Hh. These data
indicate that endogenous Krz is likely recycled before targeting Smo
into the proteasome or lysosome, similar to what occurs for
ubiquitin recycling in the endocytic pathway. The overexpressed
Krz was also very stable and completely blocked Smo accumulation
in P-compartment and A-compartment cells near the A/P boundary
(Fig. 6G); however, Krz overexpression did not alter the expression
levels of Ci, Ptc and En (Fig. 7D,E). These data indicate that the
Smo internalized by Krz was active. This was further supported by
the finding that overexpression of Krz did not block the
accumulation of Cos2 and Fu, but rather increased the levels of
Cos2 and Fu in P-compartment cells (Fig. S7A,B), which indicates
that Krz neither inhibites Smo activity nor blocks Smo protein
accumulation.
Fig. 6. Krz acts in parallel with the ESCRT-0
to promote trafficking. (A) A wing disc from
wild-type flies immunostained for Smo. Smo
accumulates in P-compartment cells where
there is Hh stimulation. (B–D) Wing discs from
flies expressing UAS-KrzRNAi and UAS-
HrsRNAi driven by MS1096-Gal4 were
stained for Smo. Arrows indicate the
accumulation of Smo in A-compartment cells
away from the A/P boundary. (E,F) Wing discs
carrying krz mutant clones with or without the
expression of HrsRNAi drievn by MS1096-
Gal4 were stained for Smo and GFP. Arrows
indicate the high accumulation of Smo in krz
mutant cells expressing Hrs RNAi. The
arrowhead indicates mild accumulation of
Smo upon Hrs RNAi expression alone.
(G–I) Wing discs expressingUAS-HA-Krz and
UAS-HrsRNAi alone, or together, through the
dorsal-compartment-specific ap-Gal4
combined with GFP were stained for Smo and
HA. The arrow identifies the inhibition of Smo
accumulation upon Krz expression, although
Hrs RNAi was simultaneously expressed.
Arrowheads indicate the mild accumulation of
Smo upon Hrs RNAi expression. GFP in I
indicates the RNAi expression domain of wing
disc. (J) A wing disc expressing UAS-HA-Krz
and UAS-Vps32RNAi driven by ap-Gal4 was
stained for Smo and HA. The arrow indicates
the high accumulation of Smo upon Vps32
RNAi expression, with Krz expressed
simultaneously. (K) A wing disc carrying hrs
mutant clones and expressing HA-Krz by
MS1096-Gal4 was stained for Smo, GFP, and
Ci. Arrow indicates Smo accumulation in hrs
mutant cells, which was not inhibited by Krz.
Arrowhead indicates the inhibition of Smo
accumulation by Krz in hrs wild-type cells.
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DISCUSSION
The regulation of Smo activation has been widely studied, and
mainly focused on the identification and characterization of Smo
mutations, including those mutations shown in earlier studies to
drive cancer formation (Taipale et al., 2000; Xie et al., 1998). It is
unclear whether the accumulation of wild-type Smo under certain
conditions can induce the activation of Hh signaling, and thus over-
proliferation of cells. In addition, it is unclear whether and how Smo
transduces Hh signaling inside the cell, although it has been
demonstrated that accumulation of Smo at the cell surface (in
Drosophila) or in cilia (in vertebrates) triggers the activation of
Smo. In this study, we found that inactivation of the ESCRT-III
complex caused severe accumulation of Smo in the MVB and
dramatic activation of Hh signaling. In contrast, inactivation of other
intracellular components, such as the ESCRTs 0–II, only induced a
mild accumulation of Smo. By carrying out genetic epistasis
analysis, and by examining the accumulation of different forms of
Smo in different cellular compartments, we found that Krz acted in
Fig. 7. See next page for legend.
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parallel with the ESCRTs 0–II pathway to promote Smo degradation
through the MVB and lysosome. The Smo that accumulated upon
the inactivation of ESCRT-III was highly active, which was likely
induced by phosphorylation but not sumoylation. We propose a
model for Smo intracellular trafficking regulated by different
pathways (Fig. 7F,G). The findings in this study uncovered a novel
mechanism for Smo activation in the intracellular compartment,
raising the possibility for tissue over-proliferation caused by an
excessive level of Smo induced by the malfunction of ESCRT-III.
The signaling of many GPCRs is controlled by endocytosis.
There are incidents of endocytic regulation at the plasma membrane,
regulation of signaling by different endocytic routes and signaling
from endosomes (Sigismund et al., 2012). Models have been
proposed for GPCR signaling in the endosomes. These include the
sustained GPCR signaling from endosomes as is likely to occur for
the thyroid-stimulating hormone GPCR (TSHR), and the acute
GPCR signaling from endosomes for the D1 dopamine receptor
(DRD1) (Irannejad and von Zastrow, 2014). It is not surprising that
malfunction of the endosomal trafficking compartments causes
Smo accumulation. It is also not surprising that Krz promotes Smo
internalization. What is surprising is that Smo can accumulate in
the MVB at such an unexpected level as to induce its
phosphorylation and activation. It is also surprising that,
independently of Ptc inhibition, the activated Smo induces high
levels of Hh target gene expression. These findings suggest a
model for GPCR activation in ESCRT-III-containing or MVB
compartments.
In this study, we show that Krz mediates the internalization of
Smo through a pathway parallel to the endosome/ESCRT-0-
mediated endocytosis. However, there is no effect of krz loss-of-
function on Smo accumulation and Hh signaling activity (Fig. 6E)
(Li et al., 2012; Molnar et al., 2011). This has been puzzling for
years. We provide the following explanations. It is possible that
other arrestins compensate for the function of krzwhen krz is lost. It
is also possible that Krz functions in parallel to the endocytosis
pathway, allowing Smo to be degraded through other pathways
when krz is lost. This latter idea is supported by findings in this
study, and also supported by the finding that Krz acts in an
ubiquitylation-independent manner to guide Smo to both
proteasome- and lysosome-mediated degradation (Li et al., 2012).
The third possibility is that endogenous Krz can only regulate the
basal level of Smo trafficking and thus the basal degradation of
Smo. Moreover, it is possible that Krz-mediated internalization of
Smo does not alter the activity of Smo in the intracellular
compartment. This hypothesis may explain, at least in part, why
overexpressed Krz completely blocks Smo accumulation without
any effect on Hh pathway activity (Fig. 7D,E).
MVB sorting is normally mediated by the ESCRT pathway, in
which the MVB cargo selection is determined by the ESCRT 0–III
protein complexes (Henne et al., 2011; Hurley and Hanson, 2010).
ESCRTs 0–II contain ubiquitin-binding proteins and are
responsible for the sequestration of ubiquitylated proteins. Hrs,
containing a ubiquitin-interacting motif (UIM), forms a heterodimer
with Stam to constitute ESCRT-0 complex. ESCRT-I contains
Vps23, also known as tumor susceptibility gene 101 (Tsg101),
which possesses a ubiquitin E2 variant (UEV) domain responsible
for cargo recognition. ESCRT-II contains Vps36, which carries a
GRAM-like ubiquitin-binding motif in EAP45 (GLUE) domain
also responsible for cargo recognition. ESCRT-III, which does not
bind ubiquitin directly, contains Vps32 and Vps20, assembles on
endosomes and further connects with Vps4 for subsequent
entrapment of GPCRs within the MVB. The ESCRT-III complex
is pivotal to cargo capture into MVB (Wollert and Hurley, 2010).
The ESCRT/MVB pathway is involved in the trafficking many
proteins, and a recent study has found that ESCRT-III and Krz are
involved in ligand-independent Notch signaling (Hori et al., 2011).
From the view of Smo trafficking, ubiquitylated Smo can be
recognized by ESCRT-0, -I, and -II, and can be clustered into the
ESCRT-III-containing compartment after deubiquitylation.
ESCRT-III does not bind ubiquitin, raising the possibility that
Krz-mediated non-ubiquitylated forms of Smo can be sorted to the
ESCRT-III-containing compartment with subsequent lysosomal
degradation. We speculate that Smo is activated in the MVB
independently of ubiquitylation and sumoylation regulation. In
support this concept, we found that the accumulation of Smo upon
inactivation of the ESCRT-III did not alter the ubiquitylation and
sumoylation of Smo (Fig. 3F,G). The other supportive finding was
that the active forms of Smo underwent lysosome-mediated
degradation (Fig. 4D). Many lysine residues in the Smo C-tail can
be either sumoylated or ubiquitylated (Li et al., 2012; Ma et al.,
2016; Xia et al., 2012; Yang et al., 2013; Zhang et al., 2017). It is
likely that Smo sumoylation counteracts ubiquitylation to regulate
Smo cell surface activation; however, the intracellular activation of
Smo does not require sumoylation or deubiquitylation. The
intracellularly accumulated Smo was phosphorylated (Fig. 3D,E),
which likely induces dimerization and activation of the protein.
It is interesting that the overexpressed Krz blocked Smo
accumulation, but increased Fu and Cos2 accumulation in P-
compartment cells (Fig. S7A,B). This indicates that the components
Fig. 7. The physical interaction of Krz and different forms of Smo is
enhanced by blocking Smo trafficking from the MVB to the lysosome.
(A) A cell-based assay to examine different forms of Smo interaction with Krz.
S2 cells were transfected with Myc–SmoWT, Myc–SmoK42R, Myc–SmoKKDE or
Myc–SmoFD, together with HA–Krz, followed by immunoprecipitation (IP) with
the anti-Myc antibody and analysis by western blotting (WB) using either the
anti-HA antibody to determine the level of Smo-bound Krz or the anti-Myc
antibody to monitor the expression of Smo. Smo was normalized by the
methods described (see Materials and Methods). The asterisk indicates
mouse IgG, which served as a loading control. Cell lysates were subjected to
western blot analysis with the anti-HA antibody to monitor Krz expression,
which also served as a loading and transfection control. Quantification of the
amount of Krz associated with Smo variants is shown in the right panel. The
signal density of Krz associated with SmoWT was defined as 1. †P<0.001
versus interaction with SmoWT in the first column (Student’s t-test). Data were
from three independent experiments. (B) S2 cells were treated with Vps32
dsRNA, MG132, BFA1 or HhN-conditioned medium. Cell lysates were
subjected to western blot analysis using the anti-Krz antibody to examine the
stability of the endogenous Krz protein. GFP served as a loading control. (C) A
wild-type wing disc was stained with the anti-Krz antibody to examine the
expression of Krz in the wing disc. (D,E) The excessively expressed Krz
downregulates the accumulation of Smo but does not alter the activity of Hh
signaling. Wing discs expressing UAS-HA-Krz driven by the ap-Gal4 were
stained for HA, Ptc, Ci and En. HA–Krz was specifically expressed in the dorsal
compartment cells but there were no differences in Ptc, Ci and En between
dorsal and ventral compartment cells. (F) A model for Smo intracellular
trafficking mechanisms uncovered in this study. Smo undergoes endocytosis
through the early and late endosomes, which is mediated by ubiquitylation.
USP8 prevents Smo ubiquitylation and elevates Smo cell surface
accumulation. Smoinact indicates the inactive forms of Smo. A parallel pathway
is identified in this study, which ismediated by Krz to sort the inactive and active
forms of Smo to the MVB and lysosome for degradation. Smoact indicates the
active forms of Smo. (G) Amodel for Smo sorting through the ESCRT complex.
One way for Smo to accumulate in the ESCRT-III-containing/MVB
compartments is the endocytosis pathway that involves ESCRT-0, ESCRT-I
and ESCRT-II. The other pathway for Smo to accumulate in the ESCRT-III/
MVB is mediated by Krz. Taken together, the inactivation of ESCRT-III
consistently leads to the accumulation of high level of Smo, which can be
activated by phosphorylation.
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downstream of Smo are accumulated and likely activated by the
overexpression of Krz, and suggests that Krz does not inhibit the
activity of Smo, Cos2 and Fu, although Krz blocks Smo
accumulation in wing disc. Upon examining the levels of Fu and
Cos2 in the intracellular compartment, we found that Fu and Cos2
were not accumulated in cells with mutated vps20 (Fig. S7C,D),
suggesting that the accumulation and activation of Smo does not
promote the accumulation of Fu and Cos2 in these cells. These data
also suggest that Krz likely acts upstream of ESCRT-III to regulate
Smo trafficking. Taken together with the finding that the
intracellular activation of Smo does not require sumoylation, we
speculate that the activation of Smo in the intracellular compartment
is mediated in a different way from its activation on the cell surface.
MATERIALS AND METHODS
Constructs, mutants and transgenes
Generation of the Myc–SmoWT, Myc–SmoSD123, Myc–SmoPKA123 and
Smo–CFP constructs was previously described (Jia et al., 2004; Liu et al.,
2007). Myc–SmoKKDE and Myc–SmoFD were constructed by fusing one
copy of the sorting signal KKDE or the 32-amino-acid peptide containing
the FDNPVY signal to the Smo C-terminus, respectively. Myc-SmoK6R,
Myc-SmoK42R andMyc-SmoKallR were as described previously (Yang et al.,
2013). HA–Ub, HA–SUMO and Flag–Ubc9 were as previously described
(Xia et al., 2012; Zhang et al., 2017). To construct tub-SmoK42R, tub-
SmoKKDE and tub-SmoFD, the tubulin-α promoter was inserted upstream of
the SmoK42R, SmoKKDE and SmoFD sequence and subcloned into the attB-
UAST vector (Xia et al., 2012). The HA–Krz construct and transgenic line
have been described previously (Zhang et al., 2017). The HA–Ptc construct
and transgenic line have been described previously (Jiang et al., 2016). All
the transgenic lines were generated by using the 75B1 VK5-attP locus to
ensure Smo protein expression at the same levels without positional effects.
The wing-specific MS1096-Gal4 and wing dorsal-compartment-specific
ap-Gal4 have been described in our previous studies (Jia et al., 2010, 2003).
vps32G5 and vps32O3 were obtained from Bloomington Stock Center (BSC)
(#39635 and #39623, respectively), and vps32 mutant clones shown in this
study were generated by using the vps32G5 mutant combined with FRT42D.
To generate survival clones, UAS-P35 was expressed in wing disc through
MS1096-Gal4. The HA–Krz transgenic insertion on the second chromosome
and the krz mutant line have been described previously (Mukherjee et al.,
2005). krz mutant clones were generated by using the krz mutant combined
with FRT82B. vps28mutant clones were generated with the vps28B9-FRT42D
stock from BSC (#39634). Genotypes for examining the activity of the Smo
transgene in smo clones were: yw hsp-flp/+ or Y; smo3 FRT40/hs-GFP
FRT40; tub-Smo-variant/+. Gal80ts flies were from BSC (#7017 and #7108).
Vps32 RNAi lines #38305 from BSC and v106823 from the Vienna
Drosophila Research Center (VDRC) gave rise to similar phenotypes, thus
v106823 was used for most of the experiments. The Hrs RNAi lines from
Bloomington (#28026 and #28964) or VDRC (v20933) gave rise to similar
phenotypes and were characterized in our previous study (Fan et al., 2013).
The Vps32–GFP line from Dr Fen-Biao Gao (University of Massachusetts)
and theVps32–GFP line fromBSC (#32559) consistently showed a dominant-
negative effect in wing discs. The transgenic line with Vps4DN carrying
E232Q mutation was a gift from Drs Harald Stenmark and Tor Erik Rusten
(Oslo University Hospital) (Rusten et al., 2007). The LAMP1–GFP linewas a
gift from Dr Helmut Kramer (UT Southwestern). The Krz RNAi line v41559
was from the VDRC and RNAi efficiency in wing disc was confirmed by use
of anti-Krz antibody (1:50, PA1-730, Thermo Scientific) upon
immunostaining of the wing disc. The Hh RNAi line v1402 was obtained
from the VDRC and characterized in our previous studies. Beclin1 (also known
as Atg6 and Vps30) RNAi (#28060), Vps34RNAi (#33384 and #64011),
Vps15 RNAi (#34092 and #57011), Atg7 RNAi (#27707), Atg8a RNAi
(#34340 and #28989) andAtg8bRNAi (#27554)were obtained from the BSC.
Immunostaining of the wing imaginal disc
Wing discs from third-instar larvae with specific genotypes were dissected
in PBS then fixed with 4% formaldehyde in PBS for 20 min. After
permeabilization with PBS supplemented with 1% Triton X-100 (PBST),
discs were incubated with the indicated primary antibodies for 3 h and the
appropriate secondary antibodies for 1 h, and washed three times with PBST
after each incubation. For wing disc treatment, 300 nM BFA1 (Sigma) in
M3 medium (Sigma; enriched with fly extract) was used and the discs were
treated for 4 h before primary and secondary antibody staining. The
same amount of DMSO in M3 medium was used as control. Primary
antibodies used were: mouse anti-Myc (1:50; 9E10, Santa Cruz
Biotechnology), anti-Flag (1:150; M2, Sigma), anti-HA (1:100; F7, Santa
Cruz Biotechnology), anti-SmoN (1:10; DSHB), anti-En (1:10; DSHB),
anti-Ptc (1:20, DSHB), anti-Ub-FK2 (1:50; PW1180, Enzo), anti-Cos2
(1:50; 5D6, gift from Dr David Robbins, University of Miami); rabbit anti-
β-Gal (1:1500; Cappel), anti-SmoP (1:10; Fan et al., 2012), anti-Krz (1:50;
PA1-730, Thermo Scientific), anti-GFP (1:200; #632377, Clonetech),
anti-Rab7 (1:3000; gift from Dr Akira Nakamura, Department of Germline
Development, Kumanoto University, Japan), anti-Fu (gift from Dr David
Robbins), anti-Vps4 (gift from Dr Erik Rusten); rat anti-Ci (1:10; 2A1,
DSHB), and guinea pig anti-Hrs (gift from Dr Hugo Bellen, Baylor College
of Medicine, USA). Affinity-purified secondary antibodies (Jackson
ImmunoResearch) for multiple labeling were used. Fluorescence signals
were acquired on an Olympus confocal microscope and images processed
with Olympus FV10-ASW v.3.1b software. About 15 imaginal discs were
scored and three to five disc images were taken for each genotype. Nearly all
wing discs exhibit the immunostaining phenotypes, and over 90% adult
wings exhibit the indicated phenotypes.
Cell culture, immunoprecipitation, western blotting, luciferase
reporter assay, cell surface staining, and statistical analysis
Drosophila S2 cells were cultured as previously described (Jiang et al.,
2016). Briefly, S2 cells were transfected with various UAST constructs
using the Effectene transfection reagent (Qiagen). At 48 h post transfection,
cells were treated with lysis buffer (100 mMNaCl, 50 mMTris-HCl pH 8.0,
1.5 mM EDTA, 10% glycerol, 1% NP-40, and protease inhibitor tablet;
Roche), followed by centrifugation at 17,949 g for 10 min. For each sample,
6×106 cells were harvested and lysed in 450 µl lysate buffer. 50 µl was saved
for direct western blots, with 4 µl for each load. The remaining 400 µl was
used for an immunoprecipitation assay, generating 30 µl samples. For
immunoprecipitation, the cell lysate was incubated with the correct primary
antibody for 2 h, and beads of protein A ultralink resin were added (Thermo
Scientific). Immunoprecipitated protein samples were resolved by SDS-
PAGE and transferred onto PVDF membranes (Millipore) for western
blotting, which was performed using the indicated antibodies and the
enhanced chemiluminescence (ECL) protocol. To normalize the level of
Smo, 50 µM MG132 and 15 mM NH4Cl was used to block Smo
degradation, and samples were normalized for loading (Fan et al., 2012).
The use of HhN-conditioned medium has been previously described (Fan
et al., 2012). For the ubiquitylation assay, S2 cells were transfected with
Myc–Smo plus HA–Ub and lysed with denaturing buffer (1% SDS, 50 mM
Tris-HCl pH 7.5, 0.5 mM EDTA, and 1 mM DTT) and incubated at 100°C
for 5 min. The lysates were then diluted with regular lysis buffer and
subjected to immunoprecipitation with the anti-Myc antibody and western
blotting with the anti-HA antibody. Experimental protocols for MG132
(Calbiochem), a proteasome inhibitor, and NH4Cl (Sigma-Aldrich), a
lysosome inhibitor, to block Smo degradation have been previously
described (Li et al., 2012; Xia et al., 2012). For BFA1 treatment, 300 nM
BFA1 was added to the medium for 4 h before harvesting the cells. The S2
cell treatment with dsRNA has been described previously (Liu et al., 2007).
dsRNA was synthesized against a specific region to knock down the
following gene expression: Vps32-1 (nucleotides 7–566); Vps32-2
(nucleotides 559 to +460 after the stop codon in the 3′-UTR); Vps20
(nucleotides 21–530); Vps15 (nucleotides 1941–2531); Vps30 (nucleotides
691–1254); Vps34 (nucleotides 2279–2820), and RNAi efficiency for each
RNAi was monitored by qRT-PCR. GFP dsRNA was synthesized against
nucleotides 6–606 and was used as the control for most RNAi experiments.
GFP RNAi efficiency was determined by western blotting using the anti-
GFP antibody to detect the expression levels of co-transfected GFP. For
qRT-PCR, total RNAwas extracted with Trizol reagent (Invitrogen). cDNA
was synthesized using SuperScript III First Strand Synthesis kit (Invitrogen)
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according to the manufacturer’s instructions. The quantitative real-time PCR
reactions were carried out using SYBR Green PCR master mix reagents
(Thermo Scientific) on the ABI StepOnePlus real-time PCR system (Applied
Biosystems). Thermal cycling was conducted at 95°C for 30 s, followed by 40
cycles of amplification at 95°C for 5 s, 55°C for 30 s and 72°C for 15 s. The
following primers were used: Vps32, 5′-GACGAACTGAATATAGCCCG-
3′ and 5′-TCATGTCGTGCACCTTGTCC-3′; Vps20, 5′-GATGTGCCCA-
CCGAAGATCT-3′ and 5′-CAGGACTTTCTTGGTTGCTT-3′.
The cell-based assay to examine Smo cell surface accumulation was
carried out by immunostaining with the anti-SmoN antibody before cell
permeabilization. After incubation with the anti-SmoN antibody at room
temperature for 30 min, cells were washed with PBS and fixed with 4%
formaldehyde in PBS for 20 min. After permeabilization with 1% PBST,
cells were then incubated with the anti-Myc antibody for 1 h (unless
autofluorescence of CFP was to be measured), appropriate secondary
antibody for 1 h, washed three times with PBST after each incubation, and
finally mounted on slides with 80% glycerol. For maximal Hh signal
strength, a UAST–Hh construct was also included in the transfection (Fan
et al., 2012). Fluorescence signals were acquired with the 60× objective on
an Olympus confocal microscope. Smo density was analyzed with ImageJ
software (NIH, version 1.48v).
For the ptc-luc reporter assay, S2 cells were cultured in six-well plates and
transfected with 50 ng tub-Ci, 20 ng renilla and 150 ng ptc-luc reporter
vectors. At 48 h post-transfection, cells were lysed for luciferase activity
analysis with the dual-luciferase reporter assay system (Promega, Madison,
WI). Renilla luciferase was used to normalize the luciferase activity. The
measurements of dual-luciferase were determined with a GLOMAX Multi
Detection System (Promega).
Presented data are representative of three experiments, with standard
deviation (s.d.) bars generated from four replicates. For statistical analysis,
Student’s t-test was used for cell culture studies involving two independent
groups.
Antibodies used in this study for western blotting were: mouse anti-Myc
(1:5000; 9E10, Santa Cruz Biotechnology), anti-HA (1:1000; F7, Santa
Cruz Biotechnology, anti-GFP (1:500; MAB3580, Millipore), rabbit anti-
Myc (1:2000; A-14, Santa Cruz Biotechnology), anti-SmoP (1:50; Fan et
al., 2012), and anti-Krz (1:2500; PA1-730, Thermo Scientific).
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